Business
Trials of AstraZeneca COVID vaccine resuming after ‘wake up call’ – Sydney Morning Herald
British clinical trials for the AstraZeneca and Oxford University coronavirus vaccine have resumed following confirmation by the Medicines Health Regulatory Authority (MHRA) that it was safe to do so, the company said on Saturday.
The patient involved in the study had been reportedly suffering from neurological symptoms associated with a rare spinal inflammatory disorder called transverse myelitis.
AstraZeneca, based in Cambridge, said it could not disclose further medical information.
“The company will continue to work with health authorities across the world and be guided as to when other clinical trials can resume to provide the vaccine broadly, equitably and at no profit during this pandemic,” AstraZeneca said.
It …
-
General12 hours agoChina and Philippines trade blame over latest South China Sea clash
-
General19 hours agoCalls for government to ‘get on with’ CSIRO Ginninderra Experiment Station land sale after three-year delay
-
Noosa News23 hours agoIs Auckland New Zealand’s New Cultural Capital?
-
Noosa News21 hours agoBetty’s Burgers National Burger Day